21 April 2024 in Prenatal Diagnosis
Objectives: This systematic review explores cardiac adaptation in monochorionic (MC) twins with twin–twin transfusion syndrome (TTTS) or selective fetal growth restriction (sFGR) and assesses the risk of congenital heart defects (CHDs).Methods: Adhering to PRISMA guidelines, 63 studies were reviewed (49 on cardiac adaptation, 13 on CHD, one on both). A narrative synthesis of cardiac adaptation patterns was performed. Additionally, a meta‐analysis compared the livebirth prevalence of CHD in TTTS and sFGR against uncomplicated MC twins.Results: In TTTS recipients, cardiac function may be impaired for diastolic, systolic, as well as global functions, while in donors, cardiac function is generally preserved. In sFGR, large twins may show hypertrophic cardiomyopathy, and small twins may show impaired systolic function. Co‐occurrence of TTTS and sFGR magnifies cardiac impact but is often underreported. Meta‐analysis for CHD prevalence revealed a relative risk ratio of 3.5 (95% CI: 2.5–4.9) for TTTS and 2.2 (95%CI: 1.3–3.5) for sFGR compared with uncomplicated MC twins.Conclusions: This study highlights the well‐documented cardiac adaptation in TTTS, contrasting with limited understanding in sFGR. Elevated CHD risks were observed in both conditions. Enhanced cardiovascular surveillance is warranted in complicated MC twin pregnancies. Future research should explore cardiac adaptation in sFGR and its long‐term consequences.
29 May 2025 in Ultrasound in Obstetrics & Gynecology
Objectives: Monochorionic diamniotic (MCDA) twins with selective fetal growth restriction (sFGR) and either continuous (cAREDF) or intermittent (iAREDF) absent or reversed end‐diastolic flow in the umbilical artery face significant fetal and neonatal risks. This study evaluated fetal and neonatal outcomes in these cases and compared outcomes for the larger twin following selective reduction (SR) vs expectant management (EM). Methods: This was an international retrospective cohort study of MCDA twin pregnancies with sFGR and cAREDF or iAREDF from five fetal medicine centers over 7 years (2016–2022). Patients were included based on an estimated fetal weight (EFW) discordance of ≥ 20% combined with cAREDF or iAREDF. We collected demographic and antenatal characteristics, longitudinal ultrasound and management data, and key perinatal outcomes, including gestational age (GA) at birth, survival rate and severe neonatal morbidity. Outcomes for the larger twin following SR vs EM were compared using logistic regression with standardization, inverse probability weighting and augmented inverse probability weighting to adjust for confounders. Average treatment effects (risk differences) were calculated for three composite outcomes (live birth at ≥ 32 weeks; live birth at ≥ 32 weeks and absence of severe neonatal morbidity; and live birth without a GA limit and absence of severe neonatal morbidity) and overall live birth. Results: Data were analyzed from 363 MCDA twin pregnancies (726 fetuses) with sFGR, which were diagnosed initially as having either cAREDF ( n = 124) or iAREDF ( n = 239). The umbilical artery flow pattern changed in 59% of pregnancies during gestation. Smaller twins with cAREDF at the final ultrasound scan before demise, delivery or intervention had a 70% survival rate, with 29% of survivors experiencing severe neonatal morbidity. In contrast, larger twins in this group had an 87% survival rate and a 26% risk of severe neonatal morbidity among survivors. For smaller twins with iAREDF at the final ultrasound scan, the survival rate was 83% and 22% of survivors were affected by severe neonatal morbidity, whereas larger twins had an 87% survival rate and a 13% risk of severe neonatal morbidity among survivors. The combined risk of adverse outcomes (fetal or neonatal demise or severe neonatal morbidity) was 52% for smaller twins with cAREDF and 37% for those with iAREDF. Among 37 cases of spontaneous fetal demise, 24 (65%) were double demise. Severe cerebral injury following single fetal demise occurred in approximately 30% of survivors. SR was associated with a 32–34% higher probability of the larger twin being liveborn ≥ 32 weeks compared with EM. This benefit seemed to align with later GA at birth and reduced rate of severe neonatal morbidity, despite similar rates of live birth. Conclusions: MCDA twins with sFGR and cAREDF or iAREDF are at high risk for demise and severe morbidity, particularly the smaller twin with cAREDF. Compared with EM, SR significantly improves the chance of the larger twin being born at ≥ 32 weeks and surviving without severe morbidity, which may be influenced by increased GA at birth. These data should inform patient counseling and management decisions. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
30 December 2023 in Placenta
24 February 2026 in BMJ Open
Introduction Selective fetal growth restriction (sFGR) is a major cause of perinatal morbidity and mortality in monochorionic diamniotic (MCDA) twin pregnancies. Current management relies on umbilical artery Doppler patterns in the smaller twin. These patterns are, however, inconsistent and do not represent a reliable severity scale, complicating clinical decision-making and parental counselling. This study aims to improve risk stratification by identifying predictors of adverse outcomes, while also evaluating the pathophysiology and multi-organ impact of sFGR in early childhood. Methods and analysis This is a prospective, international, multicentre cohort study conducted in six tertiary fetal medicine centres with expertise in complicated twin pregnancies. Recruitment began in March 2023 and will continue until December 2026, targeting 274 MCDA twin pairs with complete follow-up to develop a prediction model for adverse perinatal outcomes in sFGR at the time of diagnosis. Standardised data collection includes serial ultrasound examinations, advanced fetal imaging (cardiac, cerebral and 3D volumetric), fetal brain MRI and detailed placental phenotyping. Maternal and parental well-being are assessed during pregnancy and after birth. Neurodevelopmental outcome is evaluated up to 2 years after birth using validated tools. The statistical analysis plan includes predictive modelling with internal validation. Ethics and dissemination The study has been approved by the ethical review boards of all participating centres. Findings will be disseminated through peer-reviewed publications, international conferences and engagement with clinical guideline committees. Trial registration number NCT05952583.
2 November 2026 in BJOG: An International Journal of Obstetrics & Gynaecology
Objective: To determine the prevalence of placental histological lesions in the smaller twin's placental territory in monochorionic (MC) twins complicated by selective fetal growth restriction (sFGR), and compare it to FGR singletons. Design: Cohort study with 1:1 comparison. Setting: Leiden University Medical Center, The Netherlands. Population: Forty‐four MC twin placentas with sFGR and 44 FGR singleton placentas, histologically evaluated between 2020 and 2025. Methods: FGR was defined as birthweight < 10th percentile. sFGR was defined as birthweight discordance ≥ 20% between twins and birthweight < 10th percentile for the smaller twin. Placental parenchyma was examined using Amsterdam Consensus Statement criteria for maternal vascular malperfusion (MVM), fetal vascular malperfusion (FVM), and acute and chronic inflammation. Analyses of placental lesions were adjusted for gestational age at diagnosis of (s)FGR. Main Outcome Measures: Prevalence of histological lesions. Results: Median gestational age at birth was 37.1 weeks (IQR 32.0–38.1) for FGR singletons and 32.3 weeks (IQR 30.1–35.0) for sFGR twins ( p < 0.001). FVM was more common in smaller twins than sFGR singletons (45% versus 16%; OR 3.7 (95% CI: 1.0–13.2); p = 0.046), alongside a higher prevalence of abnormal cord insertions (84% versus 21%; p < 0.001). MVM prevalence was similar between smaller twins and FGR singletons (73% versus 75%; OR 0.8 (95% CI: 0.2–2.9); p = 0.779), as was chronic inflammation (27% versus 34%; OR 0.7 (95% CI: 0.2–2.3); p = 0.549). Conclusions: The smaller twin's placental territory in sFGR showed lesions consistent with placental insufficiency, with prevalences of MVM and chronic inflammation comparable to FGR singletons and increased prevalence of FVM. These findings suggest that placental insufficiency may be involved in the pathophysiology of sFGR alongside unequal sharing.